The parliament on Thursday voted to form an inquiry commission to probe 10 politicians in connection with allegations involving the global healthcare company, Novartis.
The company has been accused of bribing politicians, bureaucrats and doctors, and also of inflating medicine prices. The discussions in the parliament about the scandal lasted for 20 hours; separate secret voting was done for each politician involved in the allegations.
Most lawmakers voted in favor of forming an inquiry commission to probe the politicians, two of whom are former prime ministers and eight are former ministers.
The Commission will investigate the allegations of bribe, malpractice and money laundering for at least one month and will prepare a report.
Full Content: The New York Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal
Jan 14, 2025 by
CPI
EU Regulators Reevaluate Big Tech Cases as Trump Prepares to Take Office
Jan 14, 2025 by
CPI
Supreme Court Declines to Hear Realtors’ Appeal, DOJ Antitrust Probe Moves Forward
Jan 13, 2025 by
CPI
Commerzbank Chairman Doubts Amicable Merger with UniCredit After Stake Acquisition
Jan 13, 2025 by
CPI
Senator Warren Presses HUD Nominee on Rent Price-Fixing
Jan 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand